Formulation Development and Stability Studies of Norfloxacin Extended-Release Matrix Tablets

The aim of this research was to develop a new hydrophilic matrix system containing norfloxacin (NFX). Extended-release tablets are usually intended for once-a-day administration with benefits to the patient and lower discontinuation of the therapy. Formulations were developed with hydroxypropylmethy...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Paulo Renato, Mendes, Cassiana, Klein, Lilian, Sangoi, Maximiliano da Silva, Bernardi, Larissa Sakis, Silva, Marcos Antônio Segatto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780477/
https://www.ncbi.nlm.nih.gov/pubmed/24083235
http://dx.doi.org/10.1155/2013/716736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780477/
https://www.ncbi.nlm.nih.gov/pubmed/24083235
http://dx.doi.org/10.1155/2013/716736

Ejemplares similares